BridgeMD
New treatment option for HIV Infections
Official title Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
ClinicalTrials.gov ID: NCT06550804
What this study is testing
- What it's testing
- The investigators propose using an electronic adherence device that is basically a pill container that can alert when it is not opened at a scheduled time. The investigators will use this device to alert the medication user at the time when medication is supposed to be taken if the device did not get opened and a pre-identified social support person or case manager when 2 or 7 consecutive days of nonadherence are detected, respectively.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Participant
- AAMSM \>18 years with self-reported HIV infection;
- own a working cell phone;
- on ART for at least 6 months;
- have a case manager willing to participate in the study (for the clinical trial); and
You likely can't join if
- Not meeting the inclusion criteria
- Not agreeing to informed consent concerning interactions with research team, data collection, and access to medical records.
- Candidates must provide consent to obtain a copy of their viral load results during the 12 months before and following study onset to confirm...
See the full eligibility criteria
- Participant
- AAMSM \>18 years with self-reported HIV infection;
- own a working cell phone;
- on ART for at least 6 months;
- have a case manager willing to participate in the study (for the clinical trial); and
- have suboptimal adherence - either have a detectable viral load in the past 6 months, self-reported \<90% adherence based on a 3-item measure or referral by their healthcare provider because of a recognized problem with...
- report that they have a self-described meaningful relationship with the participant;
- be \>18 years of age;
- own a working cell phone and;
- be willing to provide support. For case managers, participants will have worked with clients with HIV at least 6 months prior to their participation in this study and own a working cell phone.
- Not meeting the inclusion criteria
- Not agreeing to informed consent concerning interactions with research team, data collection, and access to medical records.
- Candidates must provide consent to obtain a copy of their viral load results during the 12 months before and following study onset to confirm eligibility and explore long-term follow-up of possible effect.
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.